Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Surya, Chitra"'
Autor:
George D. Rodriguez, Nathan Warren, Roman Yashayev, Surya Chitra, Maria Amodio-Groton, Kelly Wright
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 12, Pp 2637-2648 (2024)
Abstract Introduction Appropriate oral antibiotic therapy for the treatment of acute bacterial skin and skin structure infections (ABSSSI) is a challenge, as current oral treatment guidelines do not fully cover the most common skin pathogens. Both li
Externí odkaz:
https://doaj.org/article/eafad45c321d40b98f025298c7cc9a0b
Autor:
George D. Rodriguez, Nathan Warren, Roman Yashayev, Surya Chitra, Maria Amodio-Groton, Kelly Wright
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionThe 2019 American Thoracic Society/Infectious Disease Society of America guidelines recommend respiratory fluoroquinolones to treat community-acquired bacterial pneumonia (CABP) in adults with comorbidities. Fluoroquinolones are effective
Externí odkaz:
https://doaj.org/article/88291b39d6d44b30a5e320c83d906fa1
Autor:
Shireen V. Guide, Mercedes E. Gonzalez, I. Sinem Bağcı, Brittani Agostini, Hubert Chen, Gloria Feeney, Molly Steimer, Binoy Kapadia, Kunju Sridhar, Lori Quesada Sanchez, Franshesca Gonzalez, Matthew Van Ligten, Trevor J. Parry, Surya Chitra, Lisa A. Kammerman, Suma Krishnan, M. Peter Marinkovich
Publikováno v:
New England Journal of Medicine. 387:2211-2219
Dystrophic epidermolysis bullosa is a rare genetic blistering skin disease caused by mutations inWe conducted a phase 3, double-blind, intrapatient randomized, placebo-controlled trial involving patients 6 months of age or older with genetically conf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d053a942c03e819a50c9d47264492443
https://doi.org/10.1056/nejmoa2206663
https://doi.org/10.1056/nejmoa2206663
Publikováno v:
Antibiotics, Vol 10, Iss 10, p 1195 (2021)
Introduction: Approximately 3% of hospitalized patients with community-acquired bacterial pneumonia (CABP) develop healthcare-associated Clostridioides difficile infection (HCA-CDI). The validated Davis risk score (DRS) indicates that patients with a
Externí odkaz:
https://doaj.org/article/895a3b1eab52417b9b385054e45f9944
Publikováno v:
Infectious Diseases and Therapy. 11:517-531
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::39710162f6da1b5cb47bc3ac03a84550
https://doi.org/10.1007/s40121-021-00587-4
https://doi.org/10.1007/s40121-021-00587-4
Publikováno v:
Journal of Antimicrobial Chemotherapy
Objectives The objectives of this post-hoc analysis were to examine the safety and efficacy of omadacycline by BMI categories and diabetes history in adults with acute bacterial skin and skin structure infections (ABSSSI) from two pivotal Phase III s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba0ca9294a7594e52bd1360cdab49fbf
http://europepmc.org/articles/PMC8050767
http://europepmc.org/articles/PMC8050767
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics
Background Omadacycline is a semisynthetic aminomethylcycline antibacterial derived from the tetracycline class. It is approved in the USA to treat adults with acute bacterial skin and skin-structure infections and community-acquired bacterial pneumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf5333278f3f11e1181541cd5365ae6c
https://doi.org/10.1007/s13318-020-00651-3
https://doi.org/10.1007/s13318-020-00651-3
Autor:
Tiffany R Keepers, Suzannah M. Schmidt-Malan, Robin Patel, Alisa W Serio, Melissa J. Karau, Bobbi S. Pritt, Surya Chitra, Scott A. Cunningham, Jayawant N. Mandrekar
Publikováno v:
Antimicrobial Agents and Chemotherapy
Omadacycline, vancomycin, and rifampin, as well as rifampin combination therapies, were evaluated in an experimental rat model of methicillin-resistant Staphylococcus aureus (MRSA) osteomyelitis. All treatment groups had less MRSA recovered than sali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6cd17f1f9be1a4a307d5aabb13ab21e
http://europepmc.org/articles/PMC8765317
http://europepmc.org/articles/PMC8765317
Publikováno v:
Infectious diseases and therapy. 11(1)
Acute bacterial skin and skin structure infections (ABSSSI) represent one of the most common reasons for emergency department visits, and are frequent complications of intravenous drug use in persons who inject drugs (PWID). This study examined the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02fff284e21fc65004034ae3149d0a12
https://pubmed.ncbi.nlm.nih.gov/35015255
https://pubmed.ncbi.nlm.nih.gov/35015255
Autor:
Danielle A, Nicklas, Emily C, Maggioncalda, Elizabeth, Story-Roller, Benjamin, Eichelman, Chavis, Tabor, Alisa W, Serio, Tiffany R, Keepers, Surya, Chitra, Gyanu, Lamichhane
Publikováno v:
Antimicrobial Agents and Chemotherapy
The incidence of nontuberculous mycobacterial diseases in the United States is rising and has surpassed that of tuberculosis. Most notable among the nontuberculous mycobacteria is Mycobacteroides abscessus, an emerging environmental opportunistic pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4952568e6ea346377a52df5773b7f2df
https://pubmed.ncbi.nlm.nih.gov/34662184
https://pubmed.ncbi.nlm.nih.gov/34662184